
|Articles|July 1, 2015
Working with CMOs and CDMOs
Jim Miller, President of PharmSource, spoke with BioPharm International about working with CMOs and CDMOs.
Advertisement
Jim Miller, President of PharmSource, spoke with BioPharm International about how small or mid-size pharma companies can get the attention of top-level CMOs.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5



